Skip to main content
OpenTrials

Clinical trial condition

Endocrine Sensitive HER2+/HR+ Breast Cancer

Explore clinical trials studying Endocrine Sensitive HER2+/HR+ Breast Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Endocrine Sensitive HER2+/HR+ Breast Cancer trial results

Completed

Preoperative Study With Trastuzumab, Pertuzumab and Letrozole in Breast Cancer Patients Sensitive to Hormonal Therapy

NCT02411344

Conditions
Breast Diseases, Breast Neoplasms, Endocrine Sensitive HER2+/HR+ Breast Cancer, +4 more
Locations
  • Policlinico Vittorio Emanuele Catania, CT, Italy
  • Arcispedale S. Anna Cona, FE, Italy
  • Istituto Europeo di Oncologia Milan, MI, Italy
  • Istituto Nazionale Tumori Milan, MI, Italy
View Trial Details

Related conditions